A Nucleus‐Targeting Ruthenium(II) Complex Induces DNA Condensation in Cisplatin‐Resistant Tumor Cells
Angewandte Chemie International Edition · 2025
DOI: 10.1002/anie.202504970 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2025. Verfasst von Ying Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, State Key Laboratory of Anti-Infective Drug Discovery and Development, Guangdong Basic Re…. Hauptthemen laut MEDLINE: Cisplatin, Ruthenium, Coordination Complexes, Antineoplastic Agents. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 87 Literaturangaben. Gefördert von: National Science Foundation of China, Natural Science Foundation of Guangdong Province for Distinguished Young Scholars, Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
One of the conventional ways to eradicate tumor cells is to utilize chemotherapy agents, e.g., cisplatin, to induce DNA damage. However, DNA damage repair mechanisms can significantly limit the therapeutic efficacy of cisplatin. These mechanisms enable tumor cells to repair the DNA damage caused by the drug, leading to resistance. Cisplatin and similar drugs bind to specific DNA sites without significantly altering their conformation. As a result, DNA repair enzymes can still attach to and repair the damaged DNA. To address this issue, we designed four Ru(II) complexes ( RuC3 , RuC6 , RuC9 , and RuC12 ) with high positive charges of +8 valence and regulated their nuclear accumulation levels by adjusting the length of alkyl chains. RuC9 exhibits the highest nucleus accumulation level. DNA conformation was significantly altered by inducing DNA condensation through indiscriminately neutralizing the negative charge of the DNA backbone. This significant change prevents DNA‐related enzymes from binding to DNA, ultimately leading to the efficient eradication of various tumor cell lines. To the best of our knowledge, it is the first work that kills tumor cells and overcomes cisplatin resistance through inducing DNA condensation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, State Key Laboratory of Anti-Infective Drug Discovery and Development, Guangdong Basic Research Center of Excellence for Functional Molecular Engineering, Scho…
- MOE Key Laboratory of Theoretical Organic Chemistry and Functional Molecule, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, 400201, P. R. China.
Förderung
- National Science Foundation of China
- Natural Science Foundation of Guangdong Province for Distinguished Young Scholars
- Natural Science Foundation of Guangdong Province
- Science and Technology Innovation Program of Hunan Province of China
- National Natural Science Foundation of China
Zitieren
APA
Zhou, Y., Xiong, K., Feng, T., Wu, X., Liang, J., Chen, Y., & Chao, H. (2025). A Nucleus‐Targeting Ruthenium(II) Complex Induces DNA Condensation in Cisplatin‐Resistant Tumor Cells. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202504970
Vancouver
Zhou Y, Xiong K, Feng T, Wu X, Liang J, Chen Y, et al. A Nucleus‐Targeting Ruthenium(II) Complex Induces DNA Condensation in Cisplatin‐Resistant Tumor Cells. Angewandte Chemie International Edition. 2025. doi:10.1002/anie.202504970
BibTeX
@article{Zhou2025,
author = {Zhou, Ying and Xiong, Kai and Feng, Tao and Wu, Xianbo and Liang, Jinzhe and Chen, Yu and Chao, Hui},
title = {A Nucleus‐Targeting Ruthenium(II) Complex Induces DNA Condensation in Cisplatin‐Resistant Tumor Cells},
journal = {Angewandte Chemie International Edition},
year = {2025},
doi = {10.1002/anie.202504970}
}
EUVIMED